Cargando…

A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking

Disparities exist in enrollment in clinical trials and biorepositories among adults with low socioeconomic status, racial and ethnic minority groups and individuals who live in rural areas. Diverse participation is necessary to identify the most effective treatments in different groups. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Terry C., Arnold, Connie L., Mills, Glenn, Miele, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502895/
https://www.ncbi.nlm.nih.gov/pubmed/31114788
http://dx.doi.org/10.3389/fcell.2019.00074
_version_ 1783416311172300800
author Davis, Terry C.
Arnold, Connie L.
Mills, Glenn
Miele, Lucio
author_facet Davis, Terry C.
Arnold, Connie L.
Mills, Glenn
Miele, Lucio
author_sort Davis, Terry C.
collection PubMed
description Disparities exist in enrollment in clinical trials and biorepositories among adults with low socioeconomic status, racial and ethnic minority groups and individuals who live in rural areas. Diverse participation is necessary to identify the most effective treatments in different groups. The purpose of this study was to use qualitative methods to identify factors that may affect the likelihood that members of underrepresented groups choose to participate in clinical trials and/or biobanking. We conducted 14 focus groups and seven telephone interviews in urban and rural areas of Louisiana to: (1) identify barriers and facilitators to participation; and (2) elicit input in crafting clear, culturally appropriate language and recruitment strategies. Of 103 participants, 25 were safety-net healthcare providers, 18 were primary care or oncology clinic patients, and 60 were members of social and faith-based groups. Patients and community participants were English-speaking, 79% were African American, 81% were female and 24% lived in rural areas. Barriers to participation identified were lack of knowledge about clinical trials and biobanks; limited specific information and access to participation, trust and privacy concerns about clinical trials and biobanking Facilitators included: altruism, high interest in medical research particularly studies that might benefit them or their families; plain language, culturally appropriate information; convenient access to studies; and input of a trusted provider. In addition, all primary care providers were interested in having clinical trial options available for their patients but did not have time to search for available trials. Results of this study can inform the development of education materials and strategies to increase participation of underrepresented groups in clinical trial and biobanking.
format Online
Article
Text
id pubmed-6502895
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65028952019-05-21 A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking Davis, Terry C. Arnold, Connie L. Mills, Glenn Miele, Lucio Front Cell Dev Biol Cell and Developmental Biology Disparities exist in enrollment in clinical trials and biorepositories among adults with low socioeconomic status, racial and ethnic minority groups and individuals who live in rural areas. Diverse participation is necessary to identify the most effective treatments in different groups. The purpose of this study was to use qualitative methods to identify factors that may affect the likelihood that members of underrepresented groups choose to participate in clinical trials and/or biobanking. We conducted 14 focus groups and seven telephone interviews in urban and rural areas of Louisiana to: (1) identify barriers and facilitators to participation; and (2) elicit input in crafting clear, culturally appropriate language and recruitment strategies. Of 103 participants, 25 were safety-net healthcare providers, 18 were primary care or oncology clinic patients, and 60 were members of social and faith-based groups. Patients and community participants were English-speaking, 79% were African American, 81% were female and 24% lived in rural areas. Barriers to participation identified were lack of knowledge about clinical trials and biobanks; limited specific information and access to participation, trust and privacy concerns about clinical trials and biobanking Facilitators included: altruism, high interest in medical research particularly studies that might benefit them or their families; plain language, culturally appropriate information; convenient access to studies; and input of a trusted provider. In addition, all primary care providers were interested in having clinical trial options available for their patients but did not have time to search for available trials. Results of this study can inform the development of education materials and strategies to increase participation of underrepresented groups in clinical trial and biobanking. Frontiers Media S.A. 2019-04-30 /pmc/articles/PMC6502895/ /pubmed/31114788 http://dx.doi.org/10.3389/fcell.2019.00074 Text en Copyright © 2019 Davis, Arnold, Mills and Miele. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Davis, Terry C.
Arnold, Connie L.
Mills, Glenn
Miele, Lucio
A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking
title A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking
title_full A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking
title_fullStr A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking
title_full_unstemmed A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking
title_short A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking
title_sort qualitative study exploring barriers and facilitators of enrolling underrepresented populations in clinical trials and biobanking
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502895/
https://www.ncbi.nlm.nih.gov/pubmed/31114788
http://dx.doi.org/10.3389/fcell.2019.00074
work_keys_str_mv AT davisterryc aqualitativestudyexploringbarriersandfacilitatorsofenrollingunderrepresentedpopulationsinclinicaltrialsandbiobanking
AT arnoldconniel aqualitativestudyexploringbarriersandfacilitatorsofenrollingunderrepresentedpopulationsinclinicaltrialsandbiobanking
AT millsglenn aqualitativestudyexploringbarriersandfacilitatorsofenrollingunderrepresentedpopulationsinclinicaltrialsandbiobanking
AT mielelucio aqualitativestudyexploringbarriersandfacilitatorsofenrollingunderrepresentedpopulationsinclinicaltrialsandbiobanking
AT davisterryc qualitativestudyexploringbarriersandfacilitatorsofenrollingunderrepresentedpopulationsinclinicaltrialsandbiobanking
AT arnoldconniel qualitativestudyexploringbarriersandfacilitatorsofenrollingunderrepresentedpopulationsinclinicaltrialsandbiobanking
AT millsglenn qualitativestudyexploringbarriersandfacilitatorsofenrollingunderrepresentedpopulationsinclinicaltrialsandbiobanking
AT mielelucio qualitativestudyexploringbarriersandfacilitatorsofenrollingunderrepresentedpopulationsinclinicaltrialsandbiobanking